← Open Payments lookup

DUNG TRAN: Open Payments

NPI 1851320444 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,367 in 40 payments from 10 companies in 2025. Trend: 2023 $1,463 · 2024 $1,119 · 2025 $2,367

Food & beverage: $2,255Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.28$1,026
Alkermes, Inc.2$254
E.R. Squibb & Sons, L.L.C.2$238
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$220
ABBVIE INC.1$125
Axsome Therapeutics, Inc.1$125
Vanda Pharmaceuticals Inc.1$125
Neurocrine BioSciences, Inc.1$124
Janssen Pharmaceuticals, Inc1$113
Otsuka America Pharmaceutical, Inc.1$17

Products named: UZEDY, AUSTEDO XR, COBENFY, CAPLYTA, LYBALVI, ARISTADA, VRAYLAR, Auvelity.

Industry payments across PA — which companies pay providers there.